0001437749-15-011873.txt : 20150605 0001437749-15-011873.hdr.sgml : 20150605 20150605153535 ACCESSION NUMBER: 0001437749-15-011873 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150605 ITEM INFORMATION: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 ITEM INFORMATION: Other Events FILED AS OF DATE: 20150605 DATE AS OF CHANGE: 20150605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIVEVE MEDICAL, INC. CENTRAL INDEX KEY: 0000879682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043153858 STATE OF INCORPORATION: B0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11388 FILM NUMBER: 15915823 BUSINESS ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085301900 MAIL ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 FORMER COMPANY: FORMER CONFORMED NAME: PLC SYSTEMS INC DATE OF NAME CHANGE: 19930328 8-K 1 vive20150605_8k.htm FORM 8-K vive20150605_8k.htm

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 5, 2015

 

VIVEVE MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Yukon Territory, Canada

1-11388

04-3153858

(State or other jurisdiction of

incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

150 Commercial Street

Sunnyvale, California

94086

(Address of principal executive offices)

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (408) 530-1900

 

No change

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 

 

Item 5.08. Shareholder Director Nominations.

 

The information set forth below under Item 8.01 is incorporated herein by reference.

 

Item 8.01          Other Events.

 

The board of directors of Viveve Medical, Inc. (the “Company”) has set a record date for its 2015 annual meeting of stockholders (the “2015 Annual Meeting”) as of the close of business on June 19, 2015 (the “Record Date”).  Such stockholders of record as of the Record Date will be entitled to notice of, and to vote at, the 2015 Annual Meeting.  The Company will separately send notice and proxy materials to the stockholders of record as of the Record Date with the date of the 2015 Annual Meeting, which is expected to occur on July 22, 2015. The time and location of the 2015 Annual Meeting will be as set forth in the Company's proxy statement for the 2015 Annual Meeting. 

 

Because the 2015 Annual Meeting will be held more than 30 days from the anniversary date of the 2014 annual meeting of stockholders, stockholders of the Company who wish to have a proposal considered for inclusion in the Company's proxy materials for the 2015 Annual Meeting or who wish to nominate a person for election as a director must ensure that such proposal, including any notice on Schedule 14N pursuant the Securities Exchange Act of 1934, as amended, is received by the Securities and Exchange Commission or the Company’s Corporate Secretary at 150 Commercial Street, Sunnyvale, California 94086, as applicable, on or before June 19, 2015, which the Company has determined is a reasonable time before it expects to begin to print and send its proxy materials. All stockholder director nominations and proposals must comply with Section 138 of the Yukon Business Corporations Act and the rules and regulations promulgated by the Securities and Exchange Commission, as applicable.

 
 
 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Dated: June 5, 2015

 

VIVEVE MEDICAL, INC. 

 

 

 

 

 

 

 

 

 

 

By:

/s/ Patricia Scheller 

 

 

 

Patricia Scheller 

 

 

 

Chief Executive Officer